Kiniksa Pharmaceuticals International Plc (KNSA)
40.54
-0.60
(-1.45%)
USD |
NASDAQ |
Dec 10, 16:00
40.50
-0.04
(-0.11%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Profit Margin (Quarterly): 10.19% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| CorMedix, Inc. | -- |
| NovoCure Ltd. | -22.29% |
| LivaNova Plc | 7.49% |
| ADMA Biologics, Inc. | 27.14% |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 7.60% |
| Return on Assets | 5.78% |
| Return on Invested Capital | 7.44% |
| Gross Profit Margin (Quarterly) | 53.78% |
| Operating Margin (Quarterly) | 13.28% |
| Return on Net Operating Assets | 36.36% |